pradaxa death

Texas Lawyers For Victims of Pradaxa, Pradaxa Brain Hemorrhage

Written by

Texas pradaxa lawyers filing Pradaxa lawsuits for extensive bleeding and fatalities from pradaxa in Amarillo, Austin, Beaumont , Brownsville, College Station, Corpus Christi, Dallas, Denton, El Paso ,Fort Worth , Galveston, Houston, Huntsville, Killeen, Laredo, Lubbock, Mcallen, Odessa, San Antonio , San Marcos , Texarkana, Texoma, Tyler , Victoria , Waco , Wichita Falls , Logan

The recent death of a man due to a brain hemorrhage caused by a minor trauma has underscored the dangers of the blood thinner drug Pradaxa is very alarming as pradaxa is widely prescibed as a blood thinner for seniors

According to a report at MedPageToday.com on a case study conducted by researchers at University of Utah-Salt Lake City, an 83-year-old man’s condition worsened quickly soon after he was admitted to a hospital after suffering a minor fall. Intracranial Bleeding brain had spread quickly to half his brain, taking just six hours.

According to the Journal of Neurosurgery article, also reported on by Reuters (3/7/12), the subject of the case had been taking Pradaxa for one month when he suffered a seemingly harmless ground-level fall in his home. Upon first being admitted to the hospital, the patient was alert and responsive, showing no signs causing alarm. CT scans showed small, minor hemorrhaging in the man s brain.

Two hours after being admitted to the hospital, however, new CT scans showed that the brain hemorrhaging had progressed. Although doctors made efforts to stop the hemorrhaging, the patient fell into a coma and died.

Researchers concluded, "Imbalance and falls are common in this [elderly] population, and intracranial hemorrhage resulting from even minor trauma may occur with increasing frequency as use of this drug becomes more widespread," (3/6/12). They further noted that there is no way to reverse the effects of Pradaxa in emergency situations, putting patients who suffer relatively minor falls at risk of serious consequences.

Pradaxa has no antidote and can be harmful to a senior population prone to falls. What makes matters worse is that a brain beed has symptoms akin to dementia.

Pradaxa® Internal Bleeding

In November of 2011, a European counterpart to the FDA cited over 250 cases of fatal internal bleeding linked to Pradaxa® (a differently named version of Pradaxa® was on the market in Europe before it was released in the U.S.). The FDA has also received reports of Pradaxa®-associated internal bleeding here in the U.S.

Signs and symptoms of internal bleeding from Pradaxa include:

  • Throwing up blood or vomit that looks like coffee grounds,
  • Unexplained bleeding or bruising,
  • Swelling in the ankles, feet, lower legs, hands and/or arms,
  • Excess fatigue,
  • Nosebleeds, bleeding from the gums,
  • Coughing up blood,
  • Dark colored urine,
  • Gastrointestinal (GI) bleeding,
  • Internal bleeding,
  • Kidney bleeds,
  • Brain hemorrhaging,
  • Cerebral hemorrhage,

Less than a month after European regulators asked doctors to exercise caution about using the Pradaxa bloodthinner, the FDA has decided to investigate post-marketing reports of serious bleeding patients. As of November 6, the European Medicines Agency was aware of 256 cases of serious bleeding that results in patient deaths associated with the Boeheringer Ingelheim bloodthinner.

If you are a caregiver for someone on pradaxa watch them closely and talk to the physician about alternatives. If a loved one has symptoms of internal bleeding and is on pradaxa or you have lost someone due to Pradaxa contact a Pradaxa Lawyer

Florida Actos Bladder Cancer Helpline, Actos Lawyers For Bladder Cancer

Written by

Actos has been shown to cause bladder cancer with use of over 2 years. If your parent or a loved one is showing signs of Bladder cancer call our Actos Bladder Cancer helpline to speak to an Actos lawyer.

Diabetes Treatment and Bladder Cancer

February 21, 2011

Here’s an important safety update about the diabetes medication pioglitazone (brand name: Actos), one of the 20 most prescribed drugs with 12 million prescriptions filled in 2009.

On September 17, 2010, the Food and Drug Administration (FDA) issued a safety announcement stating that it is reviewing data from a 10-year study of the type-2 diabetes drug pioglitazone for its association with an increased risk of malignant bladder cancer. The study was conducted because of the occurrence of bladder tumors in rats given a dose of pioglitazone approximately equal to that of the 30- and 45-mg-per-day doses taken by people.

The agency has already found evidence to suggest an increased risk of bladder cancer in patients with the longest exposure to pioglitazone and those taking the highest cumulative dose of the drug. The FDA’s announcement stated that “findings from studies in animals and humans suggest this is a potential safety risk that needs further study.”

However, at this time the FDA has not concluded a definite relationship between pioglitazone and bladder cancer, something that is very hard to do using data from epidemiological studies. Its review is ongoing, and the agency will update the public when it has additional information. Patients should report any side effects from pioglitazone to the FDA MedWatch program.

What You Should Do

You should not use pioglitazone ( Actos ).

In addition to possibly causing bladder cancer, the medication may not be as effective as other drugs for diabetes. It also has been found to cause liver damage, weight gain, anemia and heart failure. Also, do not use the similar but even more dangerous diabetes medication rosiglitazone (brand name: Avandia), which was banned in Europe, but due to FDA negligence is still available in the United States.

Diet and exercise are the safest and most effective ways to treat type-2 diabetes. If lifestyle modifications do not work, the next-safest option is insulin injections, followed by use of the alternative diabetes pills. The least dangerous diabetes medications that we have reviewed include glimepiride (brand name: Amaryl), glipizide (brand name: Glucotrol), glyburide (brand names: Diabeta, Glynase, Micronase), tolazamide (brand name: Tolinase), tolbutamide (brand name: Orinase), and metformin (brand name: Glucophage).

Do not stop taking any medication without first consulting your physician.

Medication Error Lawyers

Written by

Medication Error Lawyers Accepting clients who have been injured by a pharmacy medication error.

Medication errors are dangerous and cause serious injury or even death.If you or a family member have been injured due to a medication error:

  • Don’t delay get emergency care immediately
  • Contact your doctor or 911
  • Make sure to have an itemization of all medications which you are currently and medication which given to you in error
  • Do not throw away any of the prescriptions, medications, bottling or labels that were given to you.
  • Seek the advice of an experienced medication error lawyer

Examples of Pharmacy errors Include:

  • Filling the prescription with the wrong dosage
  • Filling the prescription with the wrong medication
  • Providing the wrong usage directions
  • Allowing a technician to perform the work of a pharmacist
  • Labeling errors
  • Failure to check for potential drug interactions
  • Failure to adequately counsel the patient

Many pharmacy errors result in serious injuries and large amounts of damages such as medical bills, pain and suffering and wrongful death. You must consult with a lawyer to protect you and your families legal rights.

Pradaxa Heart Attack Complications, Pradaxa lawyer

Written by

Florida Pradaxa lawyers in Miami, Ft Lauderdale, Boca Raton, West Palm Beach, Orlando, Jacksonville, Hollywood, Ft Myers, Tampa, and all of Florida are accepting cases for heart Attacks form Pradaxa.

According to Boca raton Concierge doctors there are More Concerns about Pradaxa and .Myocardial Infarctions or Heart Attacks.
Posted on January 21, 2012 the medical comments are impressive and Florida lawyers are taking notice and accepting cases for injuries from Pradaxa. Pradaxa lawyers are accepting cases from victims of Pradaxa.

Pradaxa is part of a new group of anticoagulants (thrombin X inhibitors) that eventually will allow anticoagulation by the pill route without requiring patients to alter their food and medication intake and avoid foods and medications that interfere with the anticoagulant as patients must do with Warfarin. Pradaxa additionally eliminates the need to take blood tests (INR/ PT) to monitor the dosage as one has to do with Warfarin (Coumadin).

There is a large commercial advertising campaign underway on TV and print media to encourage patients with atrial fibrillation to ask their doctors to switch them from Coumadin to Pradaxa (Dabigatrin). Pradaxa lawyers are also advertising extensively regarding the dangers of pradaxa and offering a Pradaxa lawyer, The campaign bases its claims on the RE-LY trial of 18,000 patients at 80 medical centers throughout the world who took the 150 mg dosage and had significantly fewer strokes than patients taking Warfarin. The original study was criticized because many of the patients in the Warfarin (Coumadin) group were not on enough Warfarin or at a therapeutic PT/INR to prevent embolic strokes so the comparison with Pradaxa may not be valid. Another criticism involved the fact that Pradaxa can cause major bleeding and there is no antidote to stop the bleeding. Patients on Pradaxa who are bleeding are advised to undergo hemodialysis to remove the drug from their system because there are no medications or treatments available to stop Pradaxa related bleeding.

One wonders how the Food and Drug Administration approved this product for general use under these circumstances without conducting further testing? Pradaxa lawyers seem to believe these pradaxa complications and deaths are worthey of legal action and offering victims the opportunity to get a pradaxa lawyer and pursue a claim. The issue becomes even more confusing with the addition of data presented by Ken Uchino, MD, and Adrian Hernandez MD, PhD of the Cleveland Clinic in the online version of the Archives of Internal Medicine. They claim that by reviewing the RE-LY data there is a 38% relative increase in the risk of a myocardial infarction (MI) or heart attack in the Pradaxa group. In an accompanying editorial in the same journal, clinicians at the Hadassah- Hebrew University Medical Center in Jerusalem wrote, “The robust finding that Dabigatran is associated with increased rates of MI (heart attack) is alarming and emphasizes the need for continued critical appraisal of new drugs after phase III trials.”

Thrombin X inhibitors are the wave of the future. With no way to stop the bleeding, and data on their safety and efficacy still accumulating, they are just not ready for prime time yet. Pradaxa lawyers in Miami, Ft Lauderdale, Boca Raton, West Palm Beach, Orlando, Tampa, Clearwater, Sarasota, Ft Myers and all of Florida are helping victims of Pradaxa. Florida Pradaxa lawyers are helpling victim who have lost a loved one due to pradaxa.